CHARACTERIZATION OF FOS-INDUCED OSTEOGENIC TUMORS AND TUMOR-DERIVED MURINE CELL-LINES

被引:21
作者
GORALCZYK, R
CLOSS, EI
RUTHER, U
WAGNER, EF
STRAUSS, PG
ERFLE, V
SCHMIDT, J
机构
[1] GESELL STRAHLEN & UMWELTFORSCH MBH, MOLEK ZELLPATHOL ABT, W-8042 NEUHERBERG, GERMANY
[2] RES INST MOLEC PATHOL, A-1030 VIENNA, AUSTRIA
[3] EUROPEAN MOLEC BIOL LAB, W-6900 HEIDELBERG, GERMANY
关键词
D O I
10.1111/j.1432-0436.1990.tb00545.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteogenic tumours from c-fos (MT-c-fos-LTR)-transgenic mice and from mice infected with the v-fos-bearing FBR murine osteosarcoma virus (FBR MSV) showed close morphological and neoplastic similarities. Fos mRNA expression was elevated in both types of tumours, and expression of several genes characteristic of differentiated bone cells was either lower, enhanced, or not detectable in comparison to that in normal bone. Tumour-derived cell lines showed variable levels of exogenous fos expression; bone-cell-specific genes were similarly expressed in both primary tumours and tumour-derived cell lines. Upon transplantation the tumour cells formed fibrosarcomas, some of which contained areas of focal osseochondrous differentiation. Non-tumorigenic cell lines established from bone tissue of normal and MT-c-fos-LTR transgenic mice showed osteoblastic characteristics, whereas no parathyroid hormone (PTH) response was observed in transgenic tumour cell lines in spite of high alkaline phosphatase activity. These data indicate that deregulated fos expression interferes with terminal osteogenic differentiation in v-fos- and c-fos-induced bone tumours. © 1990, International Society of Differentiation. All rights reserved.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 71 条
[51]   LOCALIZATION OF TYPE-I, TYPE-II, AND TYPE-III COLLAGEN MESSENGER-RNAS IN DEVELOPING HUMAN SKELETAL TISSUES BY INSITU HYBRIDIZATION [J].
SANDBERG, M ;
VUORIO, E .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :1077-1084
[52]   BIOCHEMICAL-CHARACTERIZATION OF A VIRUS-INDUCED OSTEOSARCOMA-LIKE OSSEOUS LESION INVITRO [J].
SCHMIDT, J ;
CLOSS, EI ;
LIVNE, E ;
ERFLE, V ;
SILBERMANN, M .
CALCIFIED TISSUE INTERNATIONAL, 1989, 45 (04) :232-242
[53]  
SCHMIDT J, 1987, AM J PATHOL, V129, P503
[54]  
SCHMIDT J, 1986, CANCER RES, V46, P3090
[55]   ESTABLISHMENT AND CHARACTERIZATION OF OSTEOGENIC CELL-LINES FROM A SPONTANEOUS MURINE OSTEO-SARCOMA [J].
SCHMIDT, J ;
STRAUSS, GP ;
SCHON, A ;
LUZ, A ;
MURRAY, AB ;
MELCHIORI, A ;
ARESU, O ;
ERFLE, V .
DIFFERENTIATION, 1988, 39 (03) :151-160
[56]   EXPRESSION OF PROTOONCOGENES IN MURINE OSTEOSARCOMAS [J].
SCHON, A ;
MICHIELS, L ;
JANOWSKI, M ;
MERREGAERT, J ;
ERFLE, V .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (01) :67-74
[57]   REQUIREMENT FOR FOS GENE-EXPRESSION IN THE TRANSCRIPTIONAL ACTIVATION OF COLLAGENASE BY OTHER ONCOGENES AND PHORBOL ESTERS [J].
SCHONTHAL, A ;
HERRLICH, P ;
RAHMSDORF, HJ ;
PONTA, H .
CELL, 1988, 54 (03) :325-334
[58]  
SCHULZ A, 1988, AM J PATHOL, V132, P233
[59]  
SENGER DR, 1988, CANCER RES, V48, P5770
[60]  
SENGER DR, 1989, ANTICANCER RES, V9, P1291